At a glance: Synthetic tetrapeptide studied in aging and telomere research. Evidence: Mostly animal and cell studies. Status: Not approved.
How it works
Epithalon (also spelled Epitalon) is a four-amino-acid peptide developed from a pineal gland extract. The proposed mechanism is that it increases the activity of telomerase, the enzyme that maintains the protective caps on the ends of chromosomes, which shorten as cells divide.
How it’s taken
By injection in the published studies. There is no established human route or dose.
What the research shows
The anti-ageing claims rest on a narrow and old evidence base.
- Cells: increased telomerase activity and telomere lengthening in cultured human cells.
- Animals: lifespan and ageing-marker studies in rodents.
- Humans: some long-term observational work in elderly patients, published mainly in Russian sources, reporting reduced mortality. These studies have not been independently replicated and would not meet modern standards for a clinical trial.
- Most of the work comes from a single research group over several decades.
Side effects
Not characterised by modern standards. The theoretical concern with any telomerase activator is that cancer cells also rely on telomerase to keep dividing.
A note on the 2026 FDA panel
In July 2026 an FDA advisory committee voted to recommend Epithalon for possible inclusion on the list of substances that compounding pharmacies may use. This is worth understanding precisely, because it is widely misreported.
- The vote is advisory and non-binding. The FDA decides.
- FDA’s own scientists recommended against all seven peptides reviewed, finding the studies too short and too small to establish safety or effectiveness.
- Nothing has been added to the list yet. Doing so would require a proposed rule, a public comment period and a final rule, a process that took more than two years the last time.
- It is not an approval, and it does not make the peptide a medicine.
What’s sold online
No approved dose exists. No regulator has approved this peptide, so there is no official dosing schedule, no quality standard for what is sold, and no doctor overseeing use. Vials sold online are made by unregulated labs, and independent testing of online peptides has repeatedly found contents that do not match the label.
Frequently asked questions
What is Epithalon?
A four-amino-acid peptide based on a pineal gland extract. Most studies come from one research group in Russia.
How is Epithalon taken?
Injection in published studies.
Is Epithalon FDA approved?
Not approved.
That means no regulator has reviewed its safety, effectiveness or manufacturing quality for this use.
What has research shown about Epithalon?
- Telomerase activity and telomere length in cell studies.
- Lifespan and aging markers in rodents.
What side effects have been reported?
- Not characterised by modern standards
Serious or less common risks are listed in the Side Effects section above.
What is still unknown about its safety?
Most of it. Epithalon has not been through the trials that establish long-term safety in people, and products sold online are made by unregulated labs. Independent testing of online peptides has repeatedly found contents that do not match the label.
References
- AJMC: FDA panel backs 6 peptides for compounding (July 2026) View source
- Buchanan Ingersoll & Rooney: what the vote means and what comes next View source